Social Capital Suvretta Holdings III (Social Capital Suvretta Holdings III) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2021)

View and export this data going back to 2021. Start your Free Trial

What is Social Capital Suvretta Holdings III 5-Year EBITDA Growth Rate?

Social Capital Suvretta Holdings III's EBITDA per Share for the six months ended in Dec. 2021 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of Social Capital Suvretta Holdings III's 5-Year EBITDA Growth Rate

For the Shell Companies subindustry, Social Capital Suvretta Holdings III's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Social Capital Suvretta Holdings III's 5-Year EBITDA Growth Rate Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Social Capital Suvretta Holdings III's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Social Capital Suvretta Holdings III's 5-Year EBITDA Growth Rate falls into.

Social Capital Suvretta Holdings III 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Social Capital Suvretta Holdings III (NAS:DNAC) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Social Capital Suvretta Holdings III 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Social Capital Suvretta Holdings III's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Social Capital Suvretta Holdings III (Social Capital Suvretta Holdings III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Social Capital Suvretta Holdings Corp III (NAS:DNAC) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

2850 W. Horizon Ridge Parkway, Suite 200, Henderson, NV, USA, 89052

Website

https://www.socialcapitalsuvrettaholdings.com

Social Capital Suvretta Holdings Corp III is a blank check company.

Executives

Jennifer A. Fox	director	C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK NY 10036
Sc Pipe Holdings Llc	10 percent owner	506 SANTA CRUZ AVE., SUITE 300, MENLO PARK CA 94025
Tolerantia, Llc	10 percent owner	110 EAST 59TH STREET, SUITE 3300, NEW YORK NY 10022
Jimenez Santos Jose Ignacio	director	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Deepak Jain	officer: Chief Operating Officer	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Darin J. Weber	officer: SVP of Regulatory Development	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Libbie Parker Mckenzie	officer: Chief Medical Officer	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
James Coulston	officer: Chief Financial Officer	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Sc Master Holdings, Llc	10 percent owner	506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025
Alan Lotvin	director	55 NOD ROAD, AVON CT 06001
Timothy Bertram	director, officer: Chief Executive Officer	C/O TENGION, INC., 2900 POTSHOP LANE, SUITE 100, EAST NORRITON PA 19403
Todd C Girolamo	officer: Chief Legal Officer	110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Uma Sinha	director	C/O EIDOS THERAPEUTICS, INC., 101 MONTGOMERY STREET, SUITE 2550, SAN FRANCISCO CA 94101
Control Empresarial De Capitales S.a. De C.v.	10 percent owner	INSURGENTES SUR #3500, PB, COL. PENA POBRE, DELEGACION TLALPAN, CP, MEXICO D.F. O5 14060
Pablo G. Legorreta	director, 10 percent owner	110 E 59TH STREET, SUITE 3300, NEW YORK NY 10022